HER2 Low Breast Carcinoma Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
HER2 Low Breast Carcinoma
Henan Cancer Hospital66 enrolled1 locationNCT05911958
Recruiting
Phase 1Phase 2
Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
Breast Cancer MetastaticAdvanced Breast CancerHER2-positive Metastatic Breast Cancer+1 more
Gustave Roussy, Cancer Campus, Grand Paris152 enrolled1 locationNCT06298084